SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer

BACKGROUND: Colorectal cancer is the third most common diagnosis. Oxaliplatin is used as first-line treatment of colon cancer. However, oxaliplatin resistance greatly reduces its therapeutic effect. SRPK1 involves in pre-mRNA splicing and tumorigenesis. How SRPK1 mediates drug resistance in colon ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jing-Qiang, Li, He-Feng, Zhu, Jing, Song, Jun-Wei, Zhang, Xian-Bin, Gong, Peng, Liu, Qiu-Yu, Zhou, Chun-Hui, Wang, Liang, Gong, Li-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243872/
https://www.ncbi.nlm.nih.gov/pubmed/34193174
http://dx.doi.org/10.1186/s12967-021-02954-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243872/
https://www.ncbi.nlm.nih.gov/pubmed/34193174
http://dx.doi.org/10.1186/s12967-021-02954-8

Ejemplares similares